Enveric Biosciences Inc (ENVB)
0.98
+0.05
(+5.89%)
USD |
NASDAQ |
May 03, 16:00
0.9616
-0.02
(-1.88%)
After-Hours: 20:00
Enveric Biosciences Free Cash Flow: -14.10M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -14.10M |
| September 30, 2023 | -15.82M |
| June 30, 2023 | -17.65M |
| March 31, 2023 | -17.82M |
| December 31, 2022 | -17.73M |
| September 30, 2022 | -18.52M |
| June 30, 2022 | -16.16M |
| March 31, 2022 | -13.54M |
| December 31, 2021 | -12.32M |
| September 30, 2021 | -10.36M |
| June 30, 2021 | -8.547M |
| March 31, 2021 | -5.434M |
| December 31, 2020 | -3.933M |
| September 30, 2020 | -2.674M |
| June 30, 2020 | -2.281M |
| March 31, 2020 | -3.878M |
| December 31, 2019 | -2.538M |
| September 30, 2019 | -2.493M |
| June 30, 2019 | -3.774M |
| March 31, 2019 | -3.102M |
| December 31, 2018 | -2.566M |
| September 30, 2018 | -2.512M |
| June 30, 2018 | -1.330M |
| March 31, 2018 | -2.357M |
| December 31, 2017 | -2.746M |
| Date | Value |
|---|---|
| September 30, 2017 | -1.543M |
| June 30, 2017 | -4.145M |
| March 31, 2017 | -3.603M |
| December 31, 2016 | -2.733M |
| September 30, 2016 | -11.86M |
| June 30, 2016 | -11.22M |
| March 31, 2016 | -10.90M |
| September 30, 2015 | -10.93M |
| June 30, 2015 | -2.066M |
| March 31, 2015 | -0.0166M |
| December 31, 2014 | -0.0432M |
| September 30, 2014 | -0.0396M |
| June 30, 2014 | -0.0461M |
| March 31, 2014 | -0.0372M |
| December 31, 2013 | -0.0216M |
| September 30, 2013 | -0.025M |
| June 30, 2013 | -0.0248M |
| March 31, 2013 | -0.0249M |
| December 31, 2012 | -0.0249M |
| September 30, 2012 | -0.0259M |
| June 30, 2012 | -0.0245M |
| March 31, 2012 | -0.0255M |
| December 31, 2011 | -0.0303M |
| September 30, 2011 | -0.0286M |
| June 30, 2011 | -0.0638M |
Free Cash Flow Range, Past 5 Years
-18.52M
Minimum
Sep 2022
-2.281M
Maximum
Jun 2020
-9.977M
Average
-10.36M
Median
Sep 2021
Free Cash Flow Benchmarks
| Seelos Therapeutics Inc | -23.91M |
| Societal CDMO Inc (DELISTED) | -9.242M |
| Cardiff Oncology Inc | -31.47M |
| BioVie Inc | -41.11M |
| Adial Pharmaceuticals Inc | -6.807M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -1.751M |
| Cash from Financing (Quarterly) | -0.1861M |
| Free Cash Flow Per Share (Quarterly) | -0.7664 |
| Free Cash Flow Yield | -666.4% |